Women more likely to misrepresent Match preferences vs. men

Gendered differences may impact how medical students rank their preferred schools when matching for residency, according to study data published in Organization Science.
Across two studies, the data show that men and women navigate the Main Residency Match differently and highlight the need for improved education on the process, according to Samuel E. Skowronek, PhD, assistant professor of management at Georgetown University’s McDonough School of Business, and Joyce C. He, PhD, assistant professor of management and organizations at UCLA Anderson School of Management.
“The National Resident

Outlook Therapeutics resubmits BLA for ONS-5010

Outlook Therapeutics resubmitted a biologics license application to the FDA for ONS-5010 for the treatment of neovascular age-related macular degeneration, according to a press release.
The company successfully appealed a 2025 complete response letter for ONS-5010 (bevacizumab-vikg, bevacizumab gamma), also known as Lytenava, and the FDA confirmed that effectiveness of the treatment has been established and that no additional trials are required. The BLA has been labeled as a class 1 resubmission, and a PDUFA date is expected within 60 days of the FDA receiving the resubmission.
ONS-5010 would

Smartwatch app accurately detects seizures in people with epilepsy

A smartwatch app accurately identified tonic-clonic seizures and seizures with major convulsions in people with epilepsy, according to data published in Neurology Open Access.
“For people who have uncontrolled tonic-clonic seizures, which can include a loss of muscle tone and airway obstruction, the risk of sudden unexpected death in epilepsy, called SUDEP, is high, particularly for those who sleep alone,” James W. Wheless, MD, FAAP, FACP, FAAN, FAES, a professor at Le Bonheur Children's Hospital in Tennessee, said in a press release from the American Academy of Neurology.
“Our

How to get involved in health care advocacy

CLEVELAND — Advocacy remains an important part of physicians’ responsibilities, as health care policies directly affect patient well-being, according to a speaker at Cleveland Clinic’s Medical Dermatology Therapy Update IV.
“Has anyone in this room ever been frustrated by a process, a system, an insurance denial or your patient cannot get access to care?” Carrie L. Davis, MD, adjunct clinical associate professor of dermatology at Indiana University School of Medicine, said during a presentation. “All of us, right? We are the people who have the power to make change and do something about it.”

Hem/onc ‘bootcamp’ improves fellows’ knowledge, confidence

CHICAGO — An interactive, case-based curriculum significantly improved hematology/oncology fellows’ foundational knowledge of the specialty, according to study results presented at ASCO Annual Meeting.
Fellows who completed the guideline-based educational program also reported greater confidence managing various clinical scenarios.
“After an internal medicine residency, most of us who enter a hem/onc fellowship jump directly into the literature — which is incredibly vast,” Chinmay Jani, MD, chief fellow in hematology/oncology at Sylvester Comprehensive Cancer Center, part of University of Miami

CMS implements work requirements for Medicaid

CMS has issued an interim final rule that implements new work requirements for adults on Medicaid.
The new statutory requirement will apply to adults who are aged 19 to 64, not pregnant and “enrolled in the Medicaid adult group or in certain section 1115 demonstrations that provide minimum essential coverage to adult beneficiaries,” according to a CMS fact sheet. As of now, 43 states and Washington D.C. offer coverage to these populations and must implement the new requirement.
Those who are affected will now be required to engage in qualifying activities — employment, community service or some

AI empowers clinicians to see the full patient

Alongside our booth at the American Psychiatric Association annual meeting in San Francisco this year, we gave away tingsha bells, which are small Tibetan cymbals on a cord that ring once, clear and long, when you strike them.
We also taught clinicians how to use them.
Take a few breaths of your own before your patient walks in. When the patient sits down, ring the bell together, and guide them through a few breaths. Listen until the sound is completely gone. Then begin, with both of you in the room.
That was the whole offer. It was not something to make you faster, but a practice to make you

Bempedoic acid may prevent dangerous blood clots

Bempedoic acid may prevent dangerous blood clots from forming in addition to reducing risk for major cardiovascular events vs. placebo in statin-intolerant people with prior CVD or at high risk for it, researchers reported.
Bempedoic acid (Nexletol, Esperion Therapeutics) significantly reduced risk for venous thromboembolism, including both deep vein thrombosis and pulmonary embolism, compared with placebo, according to a post hoc analysis of the randomized, placebo-controlled CLEAR Outcomes trial published in JAMA Cardiology.
“We know that patients that take statins, particularly rosuvastatin,

Clinical management after bariatric surgery: What providers need to know

Bariatric surgery is one of the most effective interventions for chronic weight management and the treatment of obesity. However, it is not a one-time intervention.
Long-term outcomes depend on ongoing clinical care, with clinicians playing a crucial role in monitoring progress, managing complications and providing ongoing support to patients over time.
Bariatric surgery provides durable weight loss, with studies tracking patients for 10 to 20 years demonstrating sustained results. Procedures such as biliopancreatic diversion (BPD/DS) and one-anastomosis gastric bypass (OAGB) yield the highest

Wegovy confers weight loss, heart-related benefits in menopause

Once-weekly injectable semaglutide is tied to weight loss and cardiovascular benefits for women regardless of menopause status, according to data from two post hoc analyses presented at the European Congress on Obesity.
“Menopause is more than hot flushes; it’s a cardiometabolic transition,” Emilia Huvinen, MD, PhD, associate professor and specialist in obstetrics and gynecology at University of Helsinki, told Healio. “Semaglutide offers a good option for helping with weight management and improving quality of life in menopausal women. It is also beneficial for CV health among women with